Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03289663
Other study ID # NET-06-08-76
Secondary ID
Status Active, not recruiting
Phase Phase 4
First received August 10, 2017
Last updated April 9, 2018
Start date October 2, 2017
Est. completion date September 2019

Study information

Verified date April 2018
Source Université de Lubumbashi
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Despite the mass distribution of LLINs (long-lasting insecticidal nets) as a Malaria control strategy, populations are still continuously exposed to a high frequency of malarial inoculation in some countries. The situation can be explained by a swift increase in the resistance of Anopheles to common insecticides. To preserve the gains of insecticides and improve their effectiveness, a new generation of bednets treated with piperonyl butoxide combination insectides have emerged.But more evidence is needed to plead for scale up of their usage. The lack of information relating to the additional impact of that combination on the transmission of Malaria, its relative efficacy in real-life setting and its safety in users are the rationale for more investigation.This will be a randomized controlled study on a dynamic cohort of households with 1680, 0-10 years-old subjects in 30 villages will be recruited to compute the effectiveness of this new tool.

The findings will be useful information for decision-making by national malaria control programs, their partners, the international community and the bednet manufacturers with regard to the effectiveness of the new combination of insecticides in real-life context. The results will also enable a better design of the tool in the future and a broader understanding of long-term dynamics for sustainability, as well as identification of some factors with negative impacts on the benefits of the strategy.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 1680
Est. completion date September 2019
Est. primary completion date September 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A to 10 Years
Eligibility Inclusion Criteria : -households where there are one or more children below the age of 10 years;

- Ability and willingness of the head of the household to participate based on signed informed consent (or fingerprint) and with the assistance of an impartial witness (if the head of the household is illiterate)

Exclusion Criteria :

- refusal of the head of household to participate

- known allergy to insecticides

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
synergistic combination of insecticides
third generation insecticide -treated bednets
Pyrethroids
Conventional insecticide

Locations

Country Name City State
Congo, The Democratic Republic of the Hôpital Général de Référence Saint Luc Kisantu Kongo-Central

Sponsors (3)

Lead Sponsor Collaborator
Université de Lubumbashi Centers for Disease Control and Prevention, Universiteit Antwerpen

Country where clinical trial is conducted

Congo, The Democratic Republic of the, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence rate of laboratory confirmed clinical cases of Malaria Microscopy to confirm the diagnosis of Malaria Participants will be actively followed up for 12 months. And any suspected case of clinical Malaria will immediately lead to microscopy and RDT for confirmation
Primary Sporozoite rate Sporozoite detection by ELISA to determine infectivity of anopheles Anopheles mosquitoes will be captured every 3 months during 1 year